Trial NCT04371393

View at ClinicalTrials.gov 
Org. Study IDs: GCO 08-1078-0014

Last trial update was posted on 2022-04-25

MeSH Interventions

Remestemcel-l

MeSH Conditions

Acute Lung Injury Respiratory Distress Syndrome Respiratory Distress Syndrome, Newborn Syndrome

Other Conditions

Acute Respiratory Distress Syndrome COVID Mesenchymal Stromal Cells Remestemcel-L

Stopping Reasons

At 3d interim analysis, randomization, but not follow-up, was halted by the DSMB due to low predictive probability of achieving postulated mortality benefit (pre-specified 42.5% relative mortality reduction) were the trial to complete randomization.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID